Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment

<div>Association between the hsa-miR-130a-3p expression and OS in cancer patients. (a) A forest plot of hazard ratios of hsa-miR-130a-3p in 32 types of tumors. (b) Kaplan-Meier survival curves of OS for patients stratified by the different expressions of hsa-miR-130a-3p.</div>

Evidence-Based Complementary and Alternative Medicine

fig8

Figure 8

Figure 8: Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment 

Figure 8 | Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment 